Fig. 1
From: Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
Diagram of the study and future perspectives. Workflow chart showing the process for identifying CAF-related signatures: “CAF signature” and “CAF-derived exosomes signature” with 596 and 67 genes, respectively. Patient classification is based on tumor microenvironment differences defined by CAF-derived signatures, in order to identify those patients with high/low risk of poor outcome. The results identify CAF-related biomarkers as potential tools for therapy tailoring to improve colon cancer patients’ survival. Created with BioRender.com